|
Gene: GABARAPL1 |
Gene summary for GABARAPL1 |
Gene summary. |
Gene information | Species | Human | Gene symbol | GABARAPL1 | Gene ID | 23710 |
Gene name | GABA type A receptor associated protein like 1 | |
Gene Alias | APG8-LIKE | |
Cytomap | 12p13.2 | |
Gene Type | protein-coding | GO ID | GO:0000045 | UniProtAcc | A0A024RAP5 |
Top |
Malignant transformation analysis |
Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
Malignant transformation involving gene list. |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
23710 | GABARAPL1 | LZE4T | Human | Esophagus | ESCC | 7.44e-04 | 1.05e-01 | 0.0811 |
23710 | GABARAPL1 | LZE7T | Human | Esophagus | ESCC | 8.71e-04 | 4.36e-01 | 0.0667 |
23710 | GABARAPL1 | LZE8T | Human | Esophagus | ESCC | 6.05e-06 | 4.01e-01 | 0.067 |
23710 | GABARAPL1 | LZE20T | Human | Esophagus | ESCC | 1.10e-05 | -1.64e-01 | 0.0662 |
23710 | GABARAPL1 | LZE22D1 | Human | Esophagus | HGIN | 3.64e-03 | -1.28e-01 | 0.0595 |
23710 | GABARAPL1 | LZE24T | Human | Esophagus | ESCC | 9.85e-06 | 4.50e-01 | 0.0596 |
23710 | GABARAPL1 | LZE6T | Human | Esophagus | ESCC | 4.99e-04 | 7.30e-02 | 0.0845 |
23710 | GABARAPL1 | P1T-E | Human | Esophagus | ESCC | 2.21e-05 | 2.84e-01 | 0.0875 |
23710 | GABARAPL1 | P2T-E | Human | Esophagus | ESCC | 2.84e-25 | 5.15e-01 | 0.1177 |
23710 | GABARAPL1 | P4T-E | Human | Esophagus | ESCC | 2.74e-26 | 8.61e-01 | 0.1323 |
23710 | GABARAPL1 | P5T-E | Human | Esophagus | ESCC | 2.00e-07 | -6.65e-02 | 0.1327 |
23710 | GABARAPL1 | P8T-E | Human | Esophagus | ESCC | 2.84e-10 | 3.41e-01 | 0.0889 |
23710 | GABARAPL1 | P9T-E | Human | Esophagus | ESCC | 2.07e-07 | 4.97e-01 | 0.1131 |
23710 | GABARAPL1 | P10T-E | Human | Esophagus | ESCC | 2.64e-13 | 5.56e-02 | 0.116 |
23710 | GABARAPL1 | P11T-E | Human | Esophagus | ESCC | 3.76e-13 | 2.53e-01 | 0.1426 |
23710 | GABARAPL1 | P12T-E | Human | Esophagus | ESCC | 3.28e-18 | 5.14e-01 | 0.1122 |
23710 | GABARAPL1 | P15T-E | Human | Esophagus | ESCC | 2.11e-14 | 4.68e-01 | 0.1149 |
23710 | GABARAPL1 | P16T-E | Human | Esophagus | ESCC | 8.44e-44 | 1.20e+00 | 0.1153 |
23710 | GABARAPL1 | P20T-E | Human | Esophagus | ESCC | 2.07e-06 | 3.37e-01 | 0.1124 |
23710 | GABARAPL1 | P21T-E | Human | Esophagus | ESCC | 5.54e-09 | -7.05e-02 | 0.1617 |
Page: 1 2 3 4 5 |
Transcriptomic changes along malignancy continuum. |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
Figure of enriched GO biological processes. |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | |
Colorectum | SER | |
Colorectum | MSS | |
Colorectum | MSI-H | |
Colorectum | FAP |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
Enriched GO biological processes. |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:003166826 | Thyroid | HT | cellular response to extracellular stimulus | 30/1272 | 246/18723 | 1.34e-03 | 1.29e-02 | 30 |
GO:003166926 | Thyroid | HT | cellular response to nutrient levels | 27/1272 | 215/18723 | 1.49e-03 | 1.38e-02 | 27 |
GO:002241123 | Thyroid | HT | cellular component disassembly | 47/1272 | 443/18723 | 1.60e-03 | 1.48e-02 | 47 |
GO:00000457 | Thyroid | HT | autophagosome assembly | 15/1272 | 99/18723 | 2.73e-03 | 2.25e-02 | 15 |
GO:19050377 | Thyroid | HT | autophagosome organization | 15/1272 | 103/18723 | 4.02e-03 | 2.96e-02 | 15 |
GO:000042220 | Thyroid | HT | autophagy of mitochondrion | 12/1272 | 81/18723 | 8.32e-03 | 4.79e-02 | 12 |
GO:006172620 | Thyroid | HT | mitochondrion disassembly | 12/1272 | 81/18723 | 8.32e-03 | 4.79e-02 | 12 |
GO:0022411113 | Thyroid | PTC | cellular component disassembly | 232/5968 | 443/18723 | 1.36e-19 | 1.75e-17 | 232 |
GO:0016236110 | Thyroid | PTC | macroautophagy | 167/5968 | 291/18723 | 1.51e-19 | 1.91e-17 | 167 |
GO:190300818 | Thyroid | PTC | organelle disassembly | 73/5968 | 114/18723 | 1.60e-12 | 7.12e-11 | 73 |
GO:0000422110 | Thyroid | PTC | autophagy of mitochondrion | 55/5968 | 81/18723 | 2.95e-11 | 1.10e-09 | 55 |
GO:0061726110 | Thyroid | PTC | mitochondrion disassembly | 55/5968 | 81/18723 | 2.95e-11 | 1.10e-09 | 55 |
GO:0071496113 | Thyroid | PTC | cellular response to external stimulus | 158/5968 | 320/18723 | 4.12e-11 | 1.47e-09 | 158 |
GO:000703315 | Thyroid | PTC | vacuole organization | 96/5968 | 180/18723 | 1.80e-09 | 5.13e-08 | 96 |
GO:0031668113 | Thyroid | PTC | cellular response to extracellular stimulus | 120/5968 | 246/18723 | 2.13e-08 | 4.91e-07 | 120 |
GO:0031669112 | Thyroid | PTC | cellular response to nutrient levels | 106/5968 | 215/18723 | 6.96e-08 | 1.44e-06 | 106 |
GO:0042594111 | Thyroid | PTC | response to starvation | 98/5968 | 197/18723 | 1.24e-07 | 2.41e-06 | 98 |
GO:0009267112 | Thyroid | PTC | cellular response to starvation | 80/5968 | 156/18723 | 3.52e-07 | 5.90e-06 | 80 |
GO:0031667113 | Thyroid | PTC | response to nutrient levels | 201/5968 | 474/18723 | 7.00e-07 | 1.10e-05 | 201 |
GO:000004514 | Thyroid | PTC | autophagosome assembly | 54/5968 | 99/18723 | 2.46e-06 | 3.22e-05 | 54 |
Page: 1 2 3 4 5 6 |
Enriched KEGG pathways. |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0413730 | Esophagus | HGIN | Mitophagy - animal | 23/1383 | 72/8465 | 7.69e-04 | 7.59e-03 | 6.03e-03 | 23 |
hsa046219 | Esophagus | HGIN | NOD-like receptor signaling pathway | 45/1383 | 186/8465 | 3.40e-03 | 2.54e-02 | 2.02e-02 | 45 |
hsa04137113 | Esophagus | HGIN | Mitophagy - animal | 23/1383 | 72/8465 | 7.69e-04 | 7.59e-03 | 6.03e-03 | 23 |
hsa0462114 | Esophagus | HGIN | NOD-like receptor signaling pathway | 45/1383 | 186/8465 | 3.40e-03 | 2.54e-02 | 2.02e-02 | 45 |
hsa0414010 | Esophagus | ESCC | Autophagy - animal | 101/4205 | 141/8465 | 7.60e-08 | 6.21e-07 | 3.18e-07 | 101 |
hsa04137210 | Esophagus | ESCC | Mitophagy - animal | 54/4205 | 72/8465 | 9.33e-06 | 4.96e-05 | 2.54e-05 | 54 |
hsa040689 | Esophagus | ESCC | FoxO signaling pathway | 89/4205 | 131/8465 | 1.56e-05 | 7.98e-05 | 4.09e-05 | 89 |
hsa0462122 | Esophagus | ESCC | NOD-like receptor signaling pathway | 116/4205 | 186/8465 | 2.90e-04 | 1.03e-03 | 5.30e-04 | 116 |
hsa041362 | Esophagus | ESCC | Autophagy - other | 23/4205 | 32/8465 | 8.99e-03 | 2.14e-02 | 1.09e-02 | 23 |
hsa0414015 | Esophagus | ESCC | Autophagy - animal | 101/4205 | 141/8465 | 7.60e-08 | 6.21e-07 | 3.18e-07 | 101 |
hsa0413738 | Esophagus | ESCC | Mitophagy - animal | 54/4205 | 72/8465 | 9.33e-06 | 4.96e-05 | 2.54e-05 | 54 |
hsa0406814 | Esophagus | ESCC | FoxO signaling pathway | 89/4205 | 131/8465 | 1.56e-05 | 7.98e-05 | 4.09e-05 | 89 |
hsa0462132 | Esophagus | ESCC | NOD-like receptor signaling pathway | 116/4205 | 186/8465 | 2.90e-04 | 1.03e-03 | 5.30e-04 | 116 |
hsa0413611 | Esophagus | ESCC | Autophagy - other | 23/4205 | 32/8465 | 8.99e-03 | 2.14e-02 | 1.09e-02 | 23 |
hsa04068 | Liver | NAFLD | FoxO signaling pathway | 30/1043 | 131/8465 | 4.91e-04 | 8.05e-03 | 6.49e-03 | 30 |
hsa0413712 | Liver | NAFLD | Mitophagy - animal | 18/1043 | 72/8465 | 2.27e-03 | 2.46e-02 | 1.99e-02 | 18 |
hsa040681 | Liver | NAFLD | FoxO signaling pathway | 30/1043 | 131/8465 | 4.91e-04 | 8.05e-03 | 6.49e-03 | 30 |
hsa0413713 | Liver | NAFLD | Mitophagy - animal | 18/1043 | 72/8465 | 2.27e-03 | 2.46e-02 | 1.99e-02 | 18 |
hsa0413721 | Liver | Cirrhotic | Mitophagy - animal | 39/2530 | 72/8465 | 1.38e-05 | 1.24e-04 | 7.64e-05 | 39 |
hsa041406 | Liver | Cirrhotic | Autophagy - animal | 65/2530 | 141/8465 | 3.10e-05 | 2.47e-04 | 1.52e-04 | 65 |
Page: 1 2 |
Top |
Cell-cell communication analysis |
Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
Annotation of somatic variants for genes involved in malignant transformation |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
GABARAPL1 | SNV | Missense_Mutation | c.221N>G | p.Asp74Gly | p.D74G | Q9H0R8 | protein_coding | deleterious(0.01) | possibly_damaging(0.446) | TCGA-A6-6780-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
GABARAPL1 | SNV | Missense_Mutation | novel | c.154N>T | p.Pro52Ser | p.P52S | Q9H0R8 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-AA-3984-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
GABARAPL1 | SNV | Missense_Mutation | novel | c.13N>C | p.Tyr5His | p.Y5H | Q9H0R8 | protein_coding | deleterious(0.01) | probably_damaging(0.949) | TCGA-CA-6717-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Chemotherapy | oxaliplatin | CR |
GABARAPL1 | SNV | Missense_Mutation | novel | c.242N>G | p.Asn81Ser | p.N81S | Q9H0R8 | protein_coding | deleterious(0.04) | benign(0.374) | TCGA-AJ-A3EK-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | carboplatin | CR |
GABARAPL1 | SNV | Missense_Mutation | novel | c.60N>T | p.Lys20Asn | p.K20N | Q9H0R8 | protein_coding | tolerated(0.16) | benign(0.11) | TCGA-AJ-A3EL-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
GABARAPL1 | SNV | Missense_Mutation | c.146N>C | p.Tyr49Ser | p.Y49S | Q9H0R8 | protein_coding | deleterious(0) | probably_damaging(0.975) | TCGA-AJ-A3EL-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
GABARAPL1 | SNV | Missense_Mutation | c.260N>T | p.Thr87Ile | p.T87I | Q9H0R8 | protein_coding | deleterious(0.01) | benign(0.1) | TCGA-AP-A059-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
GABARAPL1 | SNV | Missense_Mutation | c.329N>A | p.Ser110Asn | p.S110N | Q9H0R8 | protein_coding | deleterious(0.02) | probably_damaging(0.919) | TCGA-AP-A059-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
GABARAPL1 | SNV | Missense_Mutation | c.313C>A | p.Leu105Met | p.L105M | Q9H0R8 | protein_coding | deleterious(0.03) | probably_damaging(0.999) | TCGA-AP-A1E0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | paclitaxel | SD | |
GABARAPL1 | SNV | Missense_Mutation | rs370731162 | c.200N>T | p.Arg67Ile | p.R67I | Q9H0R8 | protein_coding | deleterious(0) | probably_damaging(0.938) | TCGA-AX-A05Z-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | adriamycin | SD |
Page: 1 2 |
Top |
Related drugs of malignant transformation related genes |
Identification of chemicals and drugs interact with genes involved in malignant transfromation |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |